InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Ryll Thomas, Vice-Président Senior. Director active across 1 companies, notably ImmunoGen, Inc.. Aggregated, 2 reports have been logged. The latest transaction was disclosed on 30 June 2021 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€17,9193,849 shares@ €4.6556100.0% of flow
Common Stock
SEC:0001179110-21-007314·
€17,9193,849 shares@ €4.655650.0% of flow
Common Stock
SEC:0001179110-21-007314:0·
2 of 2 declarations
About Ryll Thomas
Thomas Ryll is Senior Vice President of Technical Operations at ImmunoGen, Inc. He oversees the company's technical operations, contributing to innovation and product improvement. His role is crucial for ImmunoGen's success.
